Please try another search
Omkar Pharmachem Limited reported earnings results for the first quarter ended June 30, 2024. For the first quarter, the company reported revenue was INR 1.35 million compared to INR 1.35 million a year ago. Net income was INR 0.49 million compared to INR 0.483 million a year ago. Basic earnings per share from continuing operations was INR 0.049 compared to INR 0.048 a year ago. Diluted earnings per share from continuing operations was INR 0.049 compared to INR 0.048 a year ago.
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Revenue | 1.35 | 1.35 | 1.35 | 1.35 |
Gross Profit | 0.972 | 0.987 | 0.798 | 0.98 |
Operating Income | 0.49 | 0.734 | 0.663 | 0.905 |
Net Income | 0.49 | -0.159 | 0.663 | 0.905 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Assets | 95.92 | 97.13 | ||
Total Liabilities | 3.6 | 5.31 | ||
Total Equity | 92.33 | 91.82 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review